On Invalid Date, Lantheus Holdings (NASDAQ: LNTH) reported Q2 2023 earnings per share (EPS) of $1.38, up 119.05% year over year. Total Lantheus Holdings earnings for the quarter were $94.13 million. In the same quarter last year, Lantheus Holdings's earnings per share (EPS) was $0.63.
As of Q3 2023, Lantheus Holdings's earnings has grown 6.52% year over year. This is 56.16 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry earnings growth rate of 62.68%. Lantheus Holdings's earnings in the past year totalled $33.37 million.
What is LNTH's earnings date?
Lantheus Holdings's earnings date is Invalid Date. Add LNTH to your watchlist to be reminded of LNTH's next earnings announcement.
What was LNTH's revenue last quarter?
On Invalid Date, Lantheus Holdings (NASDAQ: LNTH) reported Q2 2023 revenue of $321.70 million up 43.79% year over year. In the same quarter last year, Lantheus Holdings's revenue was $223.72 million.
What was LNTH's revenue growth in the past year?
As of Q3 2023, Lantheus Holdings's revenue has grown 69.36% year over year. This is 58.68 percentage points higher than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 10.68%. Lantheus Holdings's revenue in the past year totalled $1.12 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.